BioPharmSignal logoBioPharmSignal

Biotech News

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026

Dermata Therapeutics (DRMA)Dermata TherapeuticsEarnings

DRMA (DRMA) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is drma.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

DRMADermata Therapeutics2026-03-26 21:15 EST

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025

DRMADermata Therapeutics2025-11-14 21:05 EST

Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

View all latest news

Dermata Therapeutics

Consumer Skincare Company Dermata Therapeutics has shifted from clinical-stage dermatology development toward a direct-to-consumer commercial skincare strategy. Tome Brand Tome is designed as a professional-style at-home skincare line built around simplified, periodic treatments rather than multi-step daily regimens. Foundational...

Recent company news

DRMADermata Therapeutics2026-08-05 12:30 EST

Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment

DRMADermata Therapeutics2026-05-13 20:05 EST

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026

DRMADermata Therapeutics2026-04-02 12:30 EST

Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System

DRMADermata Therapeutics2026-03-26 21:15 EST

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025

DRMADermata Therapeutics2026-03-10 12:30 EST

Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing

Stock data

Close
1.11 USD
Market cap
5.47M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States